Genistein, a tyrosine kinase inhibitor, blocks the 'second window of protection' 48 h after ischemic preconditioning in the rabbit

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 7, 1997, Pages 1885-1893

  Imagawa, Jun Ichi ^a   Baxter, Gary F ^a   Yellon, Derek M ^a,b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Genistein; Ischemic preconditioning; Myocardial infarction; Rabbit; Second window of protection; Tyrosine kinase

Indexed keywords

GENISTEIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031193681     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0428     Document Type: Article

References (28)

1. AKIYAMA T, ISHIDA J, NAKAGAWA S, OGAWARA H, WATANABE S, ITOH N, SHIBUYA M, FUKAMI Y, 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595.
2. AYAJIKI K, KINDERMANN M, HECKER M, FLEMING I, BUSSE R, 1996. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 78: 750-758.
3. BAINES CP, COHEN MV, DOWNEY JM, 1996. Protein tyrosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts. Circulation 94: I-661.
4. BAXTER GF, MARBER MS, PATEL VC, YELLON DM, 1994. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000.
5. BAXTER GF, GOMA FM, YELLON DM, 1995a. Duration of the "second window of protection" following ischemic preconditioning in the rabbit. J Mol Cell Cardiol 27: A162.
6. BAXTER GF, GOMA FM, YELLON DM, 1995b. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br J Pharmacol 115: 222-224.
7. BAXTER GF, MOCANU M, YELLON DM, 1996a. Diacylglycerol treatment in vivo increases ischemic tolerance 24 h later in a rabbit model of myocardial infarction. J Mol Cell Cardiol 28: A19.
8. BAXTER GF, GOODWIN RW, WRIGHT MJ, KERAC M, HEADS RJ, YELLON DM, 1996b. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br J Pharmacol 117: 1685-1692.
9. BISHOP JM, 1983. Cellular oncogenes and retroviruses. Ann Rev Biochem 52: 301-354.
10. COHEN MV, YANG X-M, DOWNEY JM, 1994. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74: 998-1004.
11. FANTL WJ, JOHNSON DE, WILLIAMS NT, 1993. Signalling by receptor tyrosine kinases. Ann Rev Biochem 62: 453-481.
12. HEADS RJ, BAXTER GF, LATCHMAN DS, YELLON DM, 1995. Delayed protection in rabbit heart following ischemic preconditioning is associated with modulation of HPS27 and superoxide dismutase at 24 h. J Mol Cell Cardiol 27: A163.
13. HOSHIDA S, KUZUYA T, FUJI H, YAMASHITA N, OE H, HORI M, SUZUKI K, TANIGUCHI N, TADA M, 1993. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol 264: H33-H39.
14. KING RA, BROADBENT JL, HEAD RJ, 1996. Absorption and excretion of the soy isoflavone genistein in rats. J Nutr 126: 176-182.
15. KUZUYA T, HOSHIDA S, YAMASHITA N, FUJI H, OE H, HORI M, KAMADA T, TADA M, 1993. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299.
16. MARBER MS, LATCHMAN DS, WALKER JM, YELLON DM, 1993. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272.
17. MAULIK N, WATANABE M, ENGELMAN RM, ZU Y-L, HUANG C-K, CORDIS GA, DAS DK, 1996. Preconditioning triggers tyrosine kinase-phospholipase D signaling leading to activation of multiple protein kinases in heart. J Mol Cell Cardiol 28: A187.
18. MAXWELL MP, HEARSE DJ, YELLON DM, 1987. Species variation in the coronary collateral circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737-746.
19. MAY MJ, WHEELER-JONES CPD, PEARSON JD, 1996. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells. Br J Pharmacol 118: 1761-1771.
20. MINAMI K, FUKUZAWA K, INOUE I, 1994. Regulation of a non-selective cation channel of cultured porcine coronary artery smooth muscle cells by tyrosine kinase. Pflügers Arch 426: 254-257.
21. MULLER JM, DAVIS MJ, CHILIAN WM, 1996. Coronary arteriolar flow-induced vasodilation signals through tyrosine kinase. Am J Physiol 270: H1878-H1884.
22. O'DELL TJ, KANDEL ER, GRANT SGN, 1991. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353: 558-560.
23. 1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem Biophys Res Commun 203: 1488-1495.
24. SONG W, FURMAN BL, PARRATT JR, 1994. Attenuation by dexamethazone of endotoxin protection against ischaemia-induced ventricular arrhythmias. Br J Pharmacol 113: 1083-1084.
25. VEGH A, PAPP JG, PARRATT JR, 1994. Prevention by dexamethazone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081-1082.
26. WIJETUNGE S, AALKJAER C, SCHACHTER M, HUGHES AD, 1992. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189: 1620-1623.
27. YELLON DM, BAXTER GF, 1995. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034.
28. YOKOSHIKI H, SUMII K, SPERELAKIS N, 1996. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 28: 807-814.